These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 35777585

  • 1. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
    Nie H, Liu XM, Yang QX, Luo XD, Zhao Y, Zhang SY.
    Int J Pharm; 2022 Aug 25; 624():121967. PubMed ID: 35777585
    [Abstract] [Full Text] [Related]

  • 2. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo.
    Nie H, Qiu B, Yang QX, Zhao Y, Liu XM, Zhang YT, Liao FL, Zhang SY.
    J Liposome Res; 2021 Mar 25; 31(1):79-89. PubMed ID: 31691619
    [Abstract] [Full Text] [Related]

  • 3. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    J Pharm Sci; 2005 Oct 25; 94(10):2266-75. PubMed ID: 16136555
    [Abstract] [Full Text] [Related]

  • 4. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
    Rensen PC, Sliedregt LA, Ferns M, Kieviet E, van Rossenberg SM, van Leeuwen SH, van Berkel TJ, Biessen EA.
    J Biol Chem; 2001 Oct 05; 276(40):37577-84. PubMed ID: 11479285
    [Abstract] [Full Text] [Related]

  • 5. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
    D'Souza AA, Devarajan PV.
    J Control Release; 2015 Apr 10; 203():126-39. PubMed ID: 25701309
    [Abstract] [Full Text] [Related]

  • 6. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X, Han M, Xu J, Geng S, Zhang Y, Ye X, Gou J, Yin T, He H, Tang X.
    Int J Pharm; 2017 Mar 30; 520(1-2):98-110. PubMed ID: 28167263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
    Bernardes GJ, Kikkeri R, Maglinao M, Laurino P, Collot M, Hong SY, Lepenies B, Seeberger PH.
    Org Biomol Chem; 2010 Nov 07; 8(21):4987-96. PubMed ID: 20820666
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
    Korb V, Tep K, Escriou V, Richard C, Scherman D, Cynober L, Chaumeil J, Dumortier G.
    Crit Rev Ther Drug Carrier Syst; 2008 Nov 07; 25(4):305-45. PubMed ID: 18540841
    [Abstract] [Full Text] [Related]

  • 12. Novel Galactosylated Poly(ethylene glycol)-Cholesterol for Liposomes as a Drug Carrier for Hepatocyte-Targeting.
    Zhang H, Xiao Y, Cui S, Zhou Y, Zeng K, Yan M, Zhao C.
    J Nanosci Nanotechnol; 2015 Jun 07; 15(6):4058-69. PubMed ID: 26369013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways.
    Kandasamy P, Mori S, Matsuda S, Erande N, Datta D, Willoughby JLS, Taneja N, O'Shea J, Bisbe A, Manoharan RM, Yucius K, Nguyen T, Indrakanti R, Gupta S, Gilbert JA, Racie T, Chan A, Liu J, Hutabarat R, Nair JK, Charisse K, Maier MA, Rajeev KG, Egli M, Manoharan M.
    J Med Chem; 2023 Feb 23; 66(4):2506-2523. PubMed ID: 36757090
    [Abstract] [Full Text] [Related]

  • 15. Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.
    Westerlind U, Westman J, Törnquist E, Smith CI, Oscarson S, Lahmann M, Norberg T.
    Glycoconj J; 2004 Feb 23; 21(5):227-41. PubMed ID: 15486455
    [Abstract] [Full Text] [Related]

  • 16. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
    Hattori Y, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2000 Dec 03; 69(3):369-77. PubMed ID: 11102677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides.
    Yamamoto T, Sawamura M, Wada F, Harada-Shiba M, Obika S.
    Bioorg Med Chem; 2016 Jan 01; 24(1):26-32. PubMed ID: 26678173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.